X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (64) 64
oncology (42) 42
female (38) 38
index medicus (37) 37
male (36) 36
middle aged (32) 32
lung cancer (30) 30
aged (29) 29
adult (24) 24
cancer (24) 24
lung neoplasms - genetics (19) 19
chemotherapy (16) 16
chemistry (14) 14
human necessities (14) 14
hygiene (14) 14
lung neoplasms - drug therapy (14) 14
medical and health sciences (14) 14
medical or veterinary science (14) 14
medicin och hälsovetenskap (14) 14
metallurgy (14) 14
organic chemistry (14) 14
peptides (14) 14
preparations for medical, dental, or toilet purposes (14) 14
investigating or analysing materials by determining theirchemical or physical properties (13) 13
lung neoplasms - pathology (13) 13
measuring (13) 13
physics (13) 13
testing (13) 13
aged, 80 and over (12) 12
beer (12) 12
biochemistry (12) 12
care and treatment (12) 12
compositions thereof (12) 12
culture media (12) 12
enzymology (12) 12
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (12) 12
microbiology (12) 12
microorganisms or enzymes (12) 12
mutation or genetic engineering (12) 12
processes using microorganisms (12) 12
propagating, preserving or maintaining microorganisms (12) 12
research (12) 12
spirits (12) 12
vinegar (12) 12
wine (12) 12
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
clinical trials (10) 10
prognosis (10) 10
smoking (10) 10
treatment outcome (10) 10
cancer and oncology (9) 9
cancer och onkologi (9) 9
carcinoma, small cell - genetics (9) 9
clinical medicine (9) 9
health aspects (9) 9
klinisk medicin (9) 9
survival (9) 9
tumor cells, cultured (9) 9
adolescent (8) 8
carcinoma, non-small-cell lung - genetics (8) 8
gene expression regulation, neoplastic (8) 8
hematology, oncology and palliative medicine (8) 8
neoplasm staging (8) 8
oncology, experimental (8) 8
patients (8) 8
risk (8) 8
risk factors (8) 8
animals (7) 7
basic medicine (7) 7
carboplatin - administration & dosage (7) 7
carcinoma, non-small-cell lung - drug therapy (7) 7
diagnosis (7) 7
genome-wide association (7) 7
lung neoplasms - blood (7) 7
lung neoplasms - mortality (7) 7
medical genetics (7) 7
medicinsk genetik (7) 7
medicinska och farmaceutiska grundvetenskaper (7) 7
tumors (7) 7
biochemistry & molecular biology (6) 6
carboplatin (6) 6
carcinoma (6) 6
case-control studies (6) 6
disease-free survival (6) 6
double-blind method (6) 6
drug therapy (6) 6
expression (6) 6
gastrin-releasing peptide (6) 6
lung neoplasms - diagnosis (6) 6
metaanalysis (6) 6
polymorphism, single nucleotide (6) 6
quality of life (6) 6
sarcoma (6) 6
specific therapeutic activity of chemical compounds ormedicinal preparations (6) 6
therapy (6) 6
analysis (5) 5
antineoplastic combined chemotherapy protocols - administration & dosage (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
carcinoma, non-small-cell lung - pathology (5) 5
carcinoma, small cell - drug therapy (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 8, pp. 1116 - 1125
Journal Article
Lancet Oncology, ISSN 1470-2045, 2012, Volume 13, Issue 10, pp. 1045 - 1054
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 11, pp. 1161 - 1170
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10028, pp. 1594 - 1596
Journal Article
The Lancet Oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. 1397 - 1410
Journal Article
Therapeutics and Clinical Risk Management, ISSN 1176-6336, 2008, Volume 4, Issue 1, pp. 149 - 162
Gastrointestinal stromal tumor (GIST) is a rare primary neoplasm of the gastrointestinal tract, mesentery, or omentum. In the past, surgery has been the only... 
Tumor | GIST | Imatinib | Stromal | Gastrointestinal | STI-571 | gastrointestinal | imatinib | stromal | tumor
Journal Article
by McKay, J.D and Hung, R.J and Han, Y and Zong, X and Carreras-Torres, R and Christiani, D.C and Caporaso, N and Johansson, M and Li, Y and Byun, J.Y and Dunning, A and Pooley, K.A and Qian, D.C and Liu, G and Bojesen, S.E and Wu, X and Marchand, L. le and Albanes, D and Bickeböller, H and Alich, M.C and Bush, W.S and Tardon, A and Rennert, G and Teare, M.D and Field, J.K and Kiemeney, L.A and Lazarus, P and Haugen, A and Schabath, M.B and Anew, A.S and Shen, H and Hong, Y.C and Yuan, J.M and Bertazzi, P.A and Pesatori, A.C and Ye, Y and Diao, N and Su, L and Zhang, R and Brhane, Y and Leighl, N and Johansen, J.S and Mellemgaard, A and Saliba, W and Haiman, C.A and Wilkens, L.R and Fernandez-Somoano, A and Fernandez-Tardon, G and Heijden, H.F.M. van der and Kim, J.H and Hu, Z and Davies, M and Brunnström, H and Manjer, J and Melander, O and Muller, D and Overvad, K and Trichopoulou, A and Tumino, R and Doherty, J.A and Barnett, M.P and Chen, C and Goodman, G.E and Cox, A and Taylor, F and Woll, P.J and Brüske, I and Wichmann, H.E and Manz, J and Muley, T.R and Risch, A and Rosenberger, A and Grankvist, K and Shepherd, F.A and Tsao, M.S and Haura, E.B and Bolca, C and Holcatova, I and Janout, V and Kontic, M and Lissowska, J and Mukeria, A and Ognjanovic, S and Orlowski, T.M and Scelo, G and Swiatkowska, B and Zaridze, D and Bakke, P and Skaug, V and Zienolddiny, S and Duell, E.J and Butler, L.M and Koh, W.P and Gao, Y.T and Houlston, R.S and McLaughlin, J and Stevens, V.L and Joubert, P and Lamontagne, M and Nickle, D.C and ... and SpiroMeta Consortium and Medicinska fakulteten and Institutionen för medicinsk biovetenskap and Institutionen för strålningsvetenskaper and Umeå universitet
Nature Genetics, ISSN 1061-4036, 2017, Volume 49, Issue 7, pp. 1126 - 1132
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 3/2014, Volume 22, Issue 3, pp. 679 - 687
Bone complications of metastatic disease, including skeletal-related events (SREs), impair patients' functioning and quality of life. In a randomized, phase 3... 
Bone resorption | Pain Medicine | Cancer-related pain | Nursing | Rehabilitation Medicine | Medicine & Public Health | Oncology | Denosumab | Bone metastases | Nursing Management/Nursing Research | SURVIVAL | SAFETY | PREVENTION | ONCOLOGY | PROSTATE-CANCER | DISEASE | HEALTH CARE SCIENCES & SERVICES | DOUBLE-BLIND | REHABILITATION | COMPLICATIONS | CARCINOMA | LONG-TERM EFFICACY | Humans | Middle Aged | Bone Neoplasms - secondary | Imidazoles - administration & dosage | Male | Antibodies, Monoclonal, Humanized - administration & dosage | Pain - drug therapy | Bone Neoplasms - physiopathology | Aged, 80 and over | Diphosphonates - therapeutic use | Adult | Female | Imidazoles - therapeutic use | Neoplasms - physiopathology | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Pain - prevention & control | Bone Resorption - drug therapy | Kaplan-Meier Estimate | Bone Density Conservation Agents - therapeutic use | Treatment Outcome | Diphosphonates - administration & dosage | Bone Density Conservation Agents - administration & dosage | Disease Progression | Bone Resorption - prevention & control | Multiple Myeloma - pathology | Adolescent | Aged | Neoplasms - pathology | Care and treatment | Cancer patients | Vitamin D | Oncology, Experimental | Multiple myeloma | Development and progression | Calcifediol | Research | Alfacalcidol | Cancer | Comparative studies | Bones | Pain | Metastasis | Drug therapy
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 8/2009, Volume 101, Issue 15, pp. 1049 - 1057
Background Cancer cells rely on angiogenesis for growth and dissemination, and small cell lung cancer (SCLC) is a highly angiogenic tumor. We evaluated... 
ANTIANGIOGENIC THERAPY | PHASE-II TRIAL | REFRACTORY MULTIPLE-MYELOMA | CLINICAL-TRIAL | ONCOLOGY | POOR-PROGNOSIS | LENALIDOMIDE PLUS DEXAMETHASONE | FIBROBLAST-GROWTH-FACTOR | TUMOR VASCULATURE | ELDERLY-PATIENTS | MAINTENANCE THERAPY | Lung Neoplasms - drug therapy | Thrombosis - chemically induced | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Small Cell Lung Carcinoma - drug therapy | Angiogenesis Inhibitors - administration & dosage | Small Cell Lung Carcinoma - blood supply | Treatment Failure | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Angiogenesis Inhibitors - adverse effects | Lung Neoplasms - blood supply | Thalidomide - adverse effects | Double-Blind Method | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | United Kingdom | Thalidomide - administration & dosage | Disease-Free Survival | Small Cell Lung Carcinoma - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quality of Life | Small Cell Lung Carcinoma - mortality | Aged | Thalidomide - therapeutic use | Neoplasm Staging | Research Design | Chemotherapy | Patient outcomes | Lung cancer, Small cell | Dosage and administration | Drug therapy | Health aspects | Thalidomide | Cancer | Survival analysis | Oncology | Cellular biology | Lung cancer | Index Medicus
Journal Article